Regulatory Updates
Sep 22, 2026•1 min read
FDA Discontinues Chlordiazepoxide Hydrochloride ANDA084700
The FDA has listed the ANDA084700 application for Chlordiazepoxide Hydrochloride 10 mg oral capsules as discontinued. Sponsor Roxane filed the original ANDA in 1976.
Regulatory Updates
Sep 15, 2026•1 min read
FDA Approves ANDA086148 for Amitriptyline Hydrochloride 150 mg Oral Tablet
The FDA has approved application ANDA086148 submitted by Roxane for a 150 mg oral tablet of amitriptyline hydrochloride, now listed as discontinued.
Regulatory Updates
Aug 29, 2026•1 min read
FDA Approves ANDA083089 for Propoxyphene Hydrochloride Capsules (Roxane)
FDA granted approval for ANDA083089 covering two oral capsule strengths of propoxyphene hydrochloride by Roxane; both products are listed as discontinued.
1